PhaseRx, Inc. (PZRXQ)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Aug 26, 2026
PhaseRx Market Cap
PhaseRx has a market cap or net worth of $12 as of October 20, 2026. It is the 53,230th most valuable company in the world and the 9,233rd biggest in the United States. Its market cap has decreased by 98.98% in one year.
Market Cap
12.00
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#9,233 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since May 18, 2016, PhaseRx's market cap has decreased from 58.15M to 12.00, a decrease of -100.00%. That is a compound annual growth rate of -77.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 12.00 | -99.49% |
| Dec 31, 2021 | 2.34K | -92.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HAVN Life Sciences | 29.00 |
| Neurobiological Technologies | 27.00 |
| TetraLogic Pharmaceuticals | 24.00 |
| Verde Science | 24.00 |
| Sienna Biopharmaceuticals | 23.00 |
| IMV Inc. | 15.00 |
| 9 Meters Biopharma | 14.00 |
| Seelos Therapeutics | 14.00 |